These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 23161174
1. Bioinformatics aggregation predictors in the study of protein conformational diseases of the human nervous system. Guidolin D, Agnati LF, Albertin G, Tortorella C, Fuxe K. Electrophoresis; 2012 Dec; 33(24):3669-79. PubMed ID: 23161174 [Abstract] [Full Text] [Related]
2. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis]. Yoshida K, Higuchi K, Ikeda S. Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474 [Abstract] [Full Text] [Related]
3. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins. Meredith SC. Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927 [Abstract] [Full Text] [Related]
4. Amyloid peptides and proteins in review. Harrison RS, Sharpe PC, Singh Y, Fairlie DP. Rev Physiol Biochem Pharmacol; 2007 Dec; 159():1-77. PubMed ID: 17846922 [Abstract] [Full Text] [Related]
5. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA. J Neurol Sci; 2005 Jun 15; 233(1-2):145-62. PubMed ID: 15896810 [Abstract] [Full Text] [Related]
6. Strategies for the inhibition of protein aggregation in human diseases. Bartolini M, Andrisano V. Chembiochem; 2010 May 17; 11(8):1018-35. PubMed ID: 20401887 [Abstract] [Full Text] [Related]
7. Protein aggregation: mechanisms and functional consequences. Invernizzi G, Papaleo E, Sabate R, Ventura S. Int J Biochem Cell Biol; 2012 Sep 17; 44(9):1541-54. PubMed ID: 22713792 [Abstract] [Full Text] [Related]
13. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Glabe CG. Neurobiol Aging; 2006 Apr 17; 27(4):570-5. PubMed ID: 16481071 [Abstract] [Full Text] [Related]
14. Analysis of protein aggregation in neurodegenerative disease. Pedersen JT, Heegaard NH. Anal Chem; 2013 May 07; 85(9):4215-27. PubMed ID: 23472885 [Abstract] [Full Text] [Related]
15. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation. Nerelius C, Fitzen M, Johansson J. Biochem Biophys Res Commun; 2010 May 21; 396(1):2-6. PubMed ID: 20494101 [Abstract] [Full Text] [Related]
16. Prediction of the aggregation propensity of proteins from the primary sequence: aggregation properties of proteomes. Castillo V, Graña-Montes R, Sabate R, Ventura S. Biotechnol J; 2011 Jun 21; 6(6):674-85. PubMed ID: 21538897 [Abstract] [Full Text] [Related]
17. Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins. Naeem A, Fazili NA. Cell Biochem Biophys; 2011 Nov 21; 61(2):237-50. PubMed ID: 21573992 [Abstract] [Full Text] [Related]
18. Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide. Gadad BS, Britton GB, Rao KS. J Alzheimers Dis; 2011 Nov 21; 24 Suppl 2():223-32. PubMed ID: 21460436 [Abstract] [Full Text] [Related]